Federal Register / Vol. 73, No. 49 / Wednesday, March 12, 2008 / Notices 13239 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ). 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

l0(a) of the Federal Advisory Committee 

Act, this notice announces a meeting of 

the National Advisory Council for 

Healthcare Research and Quality. 

DATES: The meeting will be held on 

Friday, April 4, 2008, from 9 a.m. to 3 

p.m. 

ADDRESSES: The meeting will be held at 

the Eisenberg Conference Center, 

Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland 20850. 

FOR FURTHER INFORMATION CONTACT: 

Deborah Queenan, Coordinator of the 

Advisory Council, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland, 

20850, (301) 427–1330. For press-related 

information, please contact Karen 

Migdail at (301) 427–1855. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact Mr. 

Donald L. Inniss, Director, Office of 

Equal Employment Opportunity 

Program, Program Support Center, on 

(301) 443–1144, no later than March 21, 

2008. The agenda, roster, and minutes 

are available from Ms. Bonnie Campbell, 

Committee Management Officer, Agency 

for Healthcare Research and Quality, 

540 Gaither Road, Rockville, Maryland 

20850. Ms. Campbell’s phone number is 

(301) 427–1554. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality was 

established in accordance with section 

921 (now section 931) of the Public 

Health Service Act (42 U.S.C. 299c). In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to actions of 

the Agency to enhance the quality, 

improve the outcomes, reduce the costs 

of health care services, improve access 

to such services through scientific 

research, and to promote improvements 

in clinical practice and in the 

organization, financing, and delivery of 

health care services. The Council is 

composed of members of the public, 

appointed by the Secretary, and Federal 

ex-officio members. 

II. Agenda 

On Friday, April 4, the Council 

meeting will convene at 9 a.m., with the 

call to order by the Council Chair and 

approval of previous Council minutes. 

The AHRQ director will present her 

update on current research, programs, 

and initiatives. The agenda will include 

an introduction of new Council 

members, discussion of a strategy for 

expanding measure development, and a 

discussion of program priorities for the 

2010 budget. The final agenda will be 

available on the AHRQ Web site at 

http;//www.ahrq.gov no later than 

March 31, 2008. 

Dated: February 29, 2008. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E8–4680 Filed 3–11–08; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Human 

Immunodeficiency Virus (HIV) 

Prevention Projects for the 

Commonwealth of Puerto Rico and the 

United States Virgin Islands, Program 

Announcement (PA) Number PS 08–

803 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 

5 p.m.–7:30 p.m., March 24, 2008 (Closed) 

9 a.m.–5 p.m., March 25, 2008 (Closed) 

9 a.m.–5 p.m., March 26, 2008 (Closed) 

Place: W Atlanta Hotel at Perimeter Center, 

111 Perimeter Center, Atlanta, GA 30346. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘Human Immunodeficiency 

Virus (HIV) Prevention Projects for the 

Commonwealth of Puerto Rico and the 

United States Virgin Islands, PA# PS 08–803. 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention 

(NCHHSTP) determines that agency business 

requires its consideration of this matter on 

less than 15 days notice to the public and 

that no earlier notice of this meeting was 

possible. 

Contact Person for More Information: Beth 

Wolfe, Prevention Support Office, National 

Center for HIV/AIDS, Viral Hepatitis, STD, 

and TB Prevention, CDC, 8 Corporate Square 

Boulevard,M/S E07, Atlanta, GA 30329, 

Telephone (404) 639–8531. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 7, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 08–1013 Filed 3–10–08; 9:14 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control/Initial Review Group, 

(NCIPC/IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned review group: 

Time and Date: 

8 a.m.–8:30 a.m., March 31, 2008 

(Open). 

8:30 a.m.–5p.m., March 31, 2008 

(Closed). 

Place: Embassy Suites Atlanta—

Buckhead, 3285 Peachtree Road, NE., 

Atlanta, GA 30305, Telephone (404) 

261–7733. 

Status: Portions of the meetings will 

be closed to the public in accordance 

with provisions set forth in section 

552b(c)(4) and (6), Title 5, U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to section 10(d) of 

Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and 

Human Services, and the Director, CDC, 

concerning the scientific and technical 

merit of grant and cooperative 

agreement applications received from 

academic institutions and other public 

and private profit and nonprofit 

organizations, including State and local 

government agencies, to conduct 


pwalker on PROD1PC71 with NOTICES